PhytoNexus

PhytoNexus

Department of Pharmacognosy · Herb-Drug Interaction Intelligence Platform · generated 27 Jul 2026 01:04 IST
Asphodelaceae · source entry 1

Aloe barbadensis Mill

Aloe Vera

Tier 2 · Verified 3 curated · 6 predicted 4Contraindicated Risk index 85.6
Interaction profile

01 Identity and provenance

Accepted binomial
Aloe barbadensis Mill
Common names
Aloe Vera
Family (APG IV)
Asphodelaceae
Part used
Leaves
Verification tier
Tier 2 · Verified Clinical columns reviewed and a source is on record.
Reviewer note (2026 audit)
CORRECTED - Chemical composition / class: Lupeol is a pentacyclic triterpenoid, not a phytosterol.
Reference not supplied - claim unverified against primary literature.

02 Constituent chemistry

Chemical classMarker compoundSynthetic analogue in use
polysaccharide Acemannan, glucomannan
Leaves
carboxymethyl cellulose, HPMC, PVA, PEG, Hyaluronic acid
Triterpenoid Lupeol
Leaves
none
Anthraquinone Aloe-emodin
Leaves
none
Anthraquinone Glycoside Aloin (Barbaloin)
Leaves
none

The analogue column is what makes the interaction reasoning tractable: where a constituent has a marketed structural counterpart, the counterpart's interaction profile is the starting hypothesis for the plant.

Looking up structures and physicochemical properties from PubChem…

03 Stated application

Reported activity
Topical creams and ointments, oral drug delivery
Anti-inflammatory, wound healing, bowel disease, anti cancer
laxative, antioxidant
Marketed in
Topical gel : patanjali, Himalya Oral juice: Kapiva, Dabur, Forever
capsule, tablet
Reported adverse effects
hypoglycemia, fall in blood pressure,dizziness
hypokalemia, dehydration, muscle weakness, diarrhea

04 Interaction matrix

Source column, verbatim: Antidiabetic drugs, antihypertensive diuretics
Normalised onto 3 canonical drug classes below.

Curated from the reviewed source

Drug classSeverityMechanism type ProvenanceExpected effect
Antidiabetic drugs (insulin, sulfonylureas, biguanides, GLP-1, SGLT2)
Endocrine
3Major PD-additive curated B Symptomatic hypoglycaemia, sweating, tremor, confusion; severe events rep… why ▾
Diuretics
Renal
3Major PD-additive + electrolyte-mediated curated B Hypokalaemia, hyponatraemia, dehydration, muscle weakness, cramps, arrhyt… why ▾
Antihypertensives
Cardiovascular
2Moderate PD-additive curated B Orthostatic hypotension, dizziness, syncope and falls; or loss of blood-p… why ▾

Predicted from constituent chemistry

These edges are not clinical findings. Each one is a rule inference: a constituent class in this plant is known to act on a target that the drug class also acts on. They are shown because a blank cell reads as “safe”, and for a Tier 1 entry a blank cell only means “not yet looked at”. Treat them as a literature-search agenda, not as a warning.
Drug classSeverityMechanism type ProvenanceExpected effect
Cardiac glycosides (digoxin, digitoxin)
Cardiovascular
4Contraindicated PD-additive + PK-transporter + assay interference predicted D Nausea, xanthopsia, bradyarrhythmia, AV block, ventricular tachycardia an… why ▾
Corticosteroids
Endocrine
3Major PD-additive + PK-CYP3A4 predicted D Pseudohyperaldosteronism: hypertension, hypokalaemia, oedema, myopathy; C… why ▾
Laxatives and antidiarrhoeals
Gastrointestinal
3Major PD-additive predicted D Cramping, diarrhoea, electrolyte loss, melanosis coli with chronic anthra… why ▾
Antibacterials and anthelmintics
Infection
2Moderate PK-chelation + PK-CYP predicted D Treatment failure from subtherapeutic antibiotic concentrations, or raise… why ▾
Iron, calcium and mineral supplements
Nutrition
2Moderate PK-chelation predicted D Failure of iron-deficiency correction, unexplained non-response to oral i… why ▾
Thyroid hormones and antithyroid drugs
Endocrine
2Moderate PK-absorption + PD-modulation predicted D Iatrogenic hyper- or hypothyroidism, unexplained TSH drift, loss of euthy… why ▾

05 Hazard register

The audit recorded no hazard beyond the interaction profile. The controlled-vocabulary field reads not assessed, which means the assessment has not been done rather than that it came back clear.

06 Confusable material

These entries could be mistaken for this one in trade, in the herbarium, or in a prescription. Powdered material is often indistinguishable, so the check is macroscopic, microscopic and chromatographic rather than nominal.

Aloe ferox
Cape Aloe
Asphodelaceae Same genus (Aloe)

07 Mechanism map

Chemistry sorts to the left, pharmacology to the right. Dashed edges are predicted. Drag nodes, scroll to zoom, export at 3× for a figure.

species
chemical class
marker compound
drug class
expected effect
hazard

08 Open literature

Abstract-scoped query built from this binomial, its common names and its marker compounds, run live against Europe PMC, PubMed and OpenAlex, then ranked locally against an evidence hierarchy.

Checking openFDA spontaneous reports…

09 Isomechanistic neighbours

Species whose interaction profile overlaps this one, ranked by shared severity weight rather than by count — a shared contraindication counts for more than a shared minor signal. Practical use: these are the plants you should not stack with this one, because the mechanisms summate.

SpeciesFamilyShared classes WeightJaccard
Rubia cordifolia
Manjistha
Rubiaceae 6 0.43
Senna alexandrina
Senna
Fabaceae 6 0.40
Echinacea purpurea
Echinacea
Asteraceae 6 0.40
Panax ginseng
Ginseng
Araliaceae 6 0.46
Senegalia senegal
Gum Acacia
Fabaceae 5 0.56
Salvia hispanica
Chia
Lamiaceae 5 0.56

10 References and notes

No citation is on record for this entry. That is itself the finding: the audit flagged it, and it is why the entry does not carry an A evidence grade.

Curator notes

No notes yet.

Sign in to add notes and save monographs.